Duration of high-dose interferon alfa-2b regimen for resected high-risk melanoma

Sanjiv S. Agarwala; Robert J. Gray; Michael K.K. Wong

doi:10.1200/JCO.2009.23.0334

Duration of high-dose interferon alfa-2b regimen for resected high-risk melanoma

Sanjiv S. Agarwala, Robert J. Gray, Michael K.K. Wong

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e82-e83
Journal	Journal of Clinical Oncology
Volume	27
Issue number	25
DOIs	https://doi.org/10.1200/JCO.2009.23.0334
State	Published - Sep 1 2009
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2009.23.0334

Cite this

@article{c72d6e0964554dbb8ec8a8365e7eb209,

title = "Duration of high-dose interferon alfa-2b regimen for resected high-risk melanoma",

author = "Agarwala, {Sanjiv S.} and Gray, {Robert J.} and Wong, {Michael K.K.}",

year = "2009",

month = sep,

day = "1",

doi = "10.1200/JCO.2009.23.0334",

language = "English (US)",

volume = "27",

pages = "e82--e83",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "25",

}

TY - JOUR

T1 - Duration of high-dose interferon alfa-2b regimen for resected high-risk melanoma

AU - Agarwala, Sanjiv S.

AU - Gray, Robert J.

AU - Wong, Michael K.K.

PY - 2009/9/1

Y1 - 2009/9/1

UR - http://www.scopus.com/inward/record.url?scp=70249137668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249137668&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.23.0334

DO - 10.1200/JCO.2009.23.0334

M3 - Letter

C2 - 19635995

AN - SCOPUS:70249137668

SN - 0732-183X

VL - 27

SP - e82-e83

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -

Duration of high-dose interferon alfa-2b regimen for resected high-risk melanoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this